Project Grant R01AG088115
- Federal Project Grant Award Summary The University of Washington received a $161,892 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective August 15, 2025, with an anticipated completion date of April 30, 2030. This research initiative investigates neuromuscular changes in the aging larynx, specifically addressing age-related vocal atrophy (ARVA), a condition affecting voice quality, swallowing, and communication in older adults. The...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $585,710 to Visiting Nurse Service of New York (VNS Health) under the Aging Research program (CFDA 93.866) on September 15, 2025, for a project period extending through August 31, 2030. This Stage II clinical trial funds the expansion and testing of the Virtual Caregiver Coach for You (VICCY) intervention, a 10-session virtual health coaching program designed to improve self-care and reduce stress among family...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Boston University Medical Campus a $327,000 project grant under the Aging Research program (CFDA 93.866) to identify clinically relevant cognitive subtypes in preclinical Alzheimer's disease using digital phenotyping methods. The research integrates multimodal data from traditional neuropsychological testing and digital voice recordings to develop computational models that characterize heterogeneous cognitive...
- Federal Project Grant Award Summary Vigorous Mind, Inc. received a $499,981 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) for the period August 1, 2025 through July 31, 2026. The award supports development and feasibility demonstration of an autonomous robotic system designed to deliver multicomponent interventions for reducing delirium in hospitalized elderly patients living with dementia. Delirium represents a significant clinical and...
- Federal Grant Award Summary Carevirtue Technologies, Inc. received a $499,651 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 20, 2025, with a completion date of September 19, 2026. The awardee will develop an artificial intelligence-enabled dementia care agent designed to provide 24/7 support to rural caregivers of individuals with Alzheimer's Disease and Related Dementias (ADRD). The AI agent will integrate...
- Federal Project Grant Award Summary S-3 Research LLC received a $999,556 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 20, 2025, with completion targeted for September 19, 2026. The award supports development of a multi-modal digital tool designed to improve diversity and inclusion in Alzheimer's Disease and Related Dementias (ADRD) clinical trial participation. The deliverables include a trial matching algorithm specific...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $3.42 million Project Grant to the University of California, Davis on September 15, 2025, under the Aging Research program (CFDA 93.866) to support research on capturing social and cognitive health dynamics as digital risk biomarkers of Alzheimer's Disease and related dementias (AD/ADRDS). The project, which extends through September 14, 2029, addresses critical gaps in understanding how poor social...
- WECARE Project Grant Summary George Mason University received a $677,026 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 15, 2025, through August 31, 2030. The award funds a Stage 2 efficacy trial of WECARE (Wellness Enhancement for Caregivers), a personalized digital health intervention designed specifically for Chinese American dementia caregivers. The intervention addresses documented disparities in access to...
- Federal Project Grant Award Summary The National Institute on Aging awarded a $486,000 project grant (CFDA 93.866 – Aging Research program) to Hebrew Senior Life on September 10, 2025, for a research initiative titled "Strengthening Recovery – Integrating Intrinsic Capacity Care into Post-Acute Skilled Nursing Facilities." The project, extending through June 30, 2030, will deliver a systematic adaptation and piloting of the World Health Organization's Integrated Care for Older...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $120,858 Project Grant to the University of Maryland, Baltimore effective September 1, 2025, through June 30, 2030, under the Aging Research program (CFDA 93.866). This research initiative, titled "Preserving Ability Through Virtual Exercise (PAVE): An Intervention to Increase the Physical Activity of Hospitalized Older Adults," delivers a feasibility and preliminary efficacy study examining the use of...
VOCALE Digital Intervention Research and Development The University of Washington received a $505,948 Project Grant award from the National Institute on Aging (CFDA 93.866 – Aging Research) effective March 1, 2026, through February 28, 2031, to develop and evaluate VOCALE, a web-based digital intervention designed to reduce frailty and improve quality of life among independently living residents in continuing care retirement communities (CCRCs). The deliverables include execution of a Stage II and Stage III randomized controlled trial (RCT) with 128 frail CCRC residents over an eight-week intervention period. VOCALE is specifically engineered for older adults with limited digital literacy, providing low-bandwidth, asynchronous access to self-care resources, peer support, and problem-solving tools targeting frailty prevention. The research will generate evidence on VOCALE's efficacy, mechanisms of action, and implementation feasibility within CCRC settings. Preliminary pilot data from 28 residents aged 66–92 demonstrated clinically significant improvements in quality of life (10-point RAND-36 score improvement) and large effect sizes in physical function and fatigue reduction, with sustained engagement and attrition rates of 20–25 percent. This confirmatory and exploratory trial will establish whether this scalable digital intervention can effectively address the high prevalence of frailty affecting over half of the approximately 700,000 residents across 2,000 CCRCs in the United States, while overcoming implementation barriers such as limited facility space and staffing constraints.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $505.9k | 2/26/26 |